M&A deals, company strategies, pipeline updates and more
Follow our coverage of the 2019 J.P. Morgan Healthcare Conference in San Francisco
AstraZeneca has teamed up with Repositive to share molecular data from patient-derived xenografts.
Florence Healthcare has picked up seed funding to help clinical trial sites switch from paper files to the cloud.
Immuno-oncology upstart Forty Seven has tapped Medidata for technology as it gears up for two early-stage clinical trials.
The Garvan Institute has founded a whole genome sequencing subsidiary, given it access to an Illumina HiSeq X Ten and tapped DNAnexus for its cloud platform.
The Scripps Research Institute has rolled out DataDirect Networks’ data management system across its cryo-electron microscopy research teams.
Biogen has made Medidata Rave its primary clinical trial technology platform, continuing the shift in power in the eClinical market.
HHS has set up a challenge to identify ways in which blockchain can support privacy, security and scalability in health IT and research data.
A team at Cincinnati Children's Hospital Medical Center has created a tool to improve analysis of adverse event data gathered by FDA.
Siemens Venture Capital has invested in Riffyn, a developer of R&D design software that is weeks away from introducing its first commercial product.
Genedata has landed a deal with Evotec, continuing a busy 18-month period in which it has signed up Bayer, Boehringer Ingelheim and Merck KGaA.